Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.05 GBP per share
-
Shares outstanding
-
84,213,667
-
Total 13F shares
-
68,611,559
-
Share change
-
+828,506
-
Total reported value
-
$3,186,422,108
-
Put/Call ratio
-
24%
-
Price per share
-
$46.44
-
Number of holders
-
192
-
Value change
-
+$45,832,094
-
Number of buys
-
103
-
Number of sells
-
71
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q4 2024
As of 31 Dec 2024,
Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) was held by
192 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,611,559 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, NEA Management Company, LLC, Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, MAVERICK CAPITAL LTD, WELLINGTON MANAGEMENT GROUP LLP, Vivo Capital, LLC, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, JENNISON ASSOCIATES LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
192
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.